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Patients with end-stage renal disease (ESRD) are immunocompromised and are candidates for renal transplantation, but HHV8 seroprevalence in ESRD patients has not been well documented. A cross-sectional study of 286 ESRD patients and 281 matched subjects without kidney disease was conducted at the First People's Hospital of Huzhou, Zhejiang province to explore the epidemiologic features of HHV8 among ESRD patients in China. Blood samples were collected and HHV8 antibodies and serologic indices were measured. The seroprevalence of HHV8 was 15.3% for ESRD patients and 8.9% for the comparison group. A significant difference in the geometric mean titer (GMT) of the HHV8 antibodies was detected between ESRD patients and the comparison group (617.1 vs 291.7; P = 0.042). The average level of hemoglobin was 11.56 ± 1.78 g/dL for the ESRD group and 13.73 ± 1.42 g/dL for the comparison group, (P > 0.05). Multiple linear regression revealed a negative association between HHV8 infection and plasma hemoglobin concentration (β = −0.682, P = 0.036). We found a higher HHV8 prevalence and a higher level of HHV8 antibody GMT in ESRD patients than the comparison group, which indicate a high risk of posttransplantation KS. for KS, which may partly due to immunosuppression therapy. 6, 7 HHV8 antibodies, however, were frequently detected before the initiation of immunosuppressive therapy, 8 indicating an early infection of HHV8 in patients with end-stage renal disease (ESRD). [9] [10] [11] A high prevalence of HHV8 was found in ESRD patients undergoing hemodialysis, 12,13 whom were candidates for renal transplantation and are usually under an immunodeficient state. [14] [15] [16] To a certain extent, HHV8 infection may increase the disease burden of ESRD patients and the risk for KS development after renal graft.
In a multicenter cross-sectional study, the prevalence of chronic kidney disease (CKD) was estimated to be 10.8% (119.5 million patients)
in China. 17 Another study reported there were a total of 65 074 ESRD patients in China, with an annual increasing rate of prevalence to be 52.9%. 18 An inevitable and frequent complication of CKD is anemia, Qiwen Fang, Xiaoyi Wang, and Zhenqiu Liu contributed equally to this work.
which in turn affects the CKD progression and patient survival, and the low hemoglobin level was detected to be associated with elevated KS antibody titer and the risk of KS development. [19] [20] [21] [22] 
| Blood collection
Venous blood was collected from participants by professional nurses using disposable sterile needles and tubes. Serum samples were stored at −80°C for further serological testing. Specimens were coded by unique identification numbers and were analyzed without knowledge of the personal identity of the study participants. The study protocol was reviewed and approved by the Institutional Review Board of Fudan University, China. All study participants provided written informed consent.
| Laboratory testing
HHV8 serology: An immunofluorescence assay (IFA) was performed to detect the presence of lytic or latent antigen specific antibodies, as previously reported. 23 Briefly, Spodoptera frugiperda clone nine cells infected with baculovirus-expressing ORF65 antigen (lytic antigen) or the ORF73 (latent nucleic antigen, LANA) were harvested, fixed, and spotted individually on separate slides for further sample testing. All serum samples were then tested at 1:40 dilution. Sera from KS patients and healthy individuals, who were previously tested seropositive and seronegative, respectively, were used as controls. Only those sera scoring positive by both assays were characterized as HHV8
seropositive. Each slide was read independently by two experienced laboratory workers. To determine geometric mean titer (GMT) of HHV8 antibody, HHV8 seropositive subjects were further tested by IFA on serially diluted samples ranging from 1:40 to 1:10240.
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The C-reactive protein (CRP) level was measured with a fluorescence polarization immunoassay (TDxFLEx analyzer; Abbott Laboratories, Abbott Park, IL). All other laboratory tests were performed using standard clinical assays.
All the above serological tests were performed by two experienced technicians from the key laboratory of Fudan University, according to the manufacturers' standard protocols.
| Statistical analysis
Both medical recorders and laboratory testing results were doubleentered and managed in EpiData 3. detected (Mann-Whitney U = 355.5, P = 0.042, Figure 1) .
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| The distribution of hemoglobin among patients
The average hemoglobin concentration level was 11.56 ± 1.78 g/dL and 13.73 ± 1.42 g/dL for the ESRD and comparison group, respectively (P > 0.05). We further compared the average hemoglobin concentration across different groups. Among patients with ESRD, the average hemoglobin concentration was significantly lower in HHV8 seropositive patients as compared to HHV8-negative patients (9.36 g/dL vs 10.00 g/dL P = 0.038), Meanwhile, within the control group, the average hemoglobin concentration was significantly lower in HHV8 seropositive individuals compared to HHV8-negative individuals (12.67 g/dL vs 13.47 g/dL; P = 0.011; Figure 2 ).
| Multivariate analysis on the correlates of hemoglobin level
Additionally, we explored the potential predictors for the average Hb concentration among study subjects. A multivariate linear regression analysis was performed to identify independent predictors of Hb concentration level, and the results showed that gender, ESRD status (β = −3.319, P < 0.001), HHV8 status (β = −0.682, P = 0.036), and CRP (β = −0.224, P = 0.033) were independently and negatively associated with Hb level among participants. While diabetes, PTH, and hypertension were not correlated with Hb level (Table 2 ). These results indicate that for the first time, a significant association was found between HHV8 seropositivity and hemoglobin level in patients with ESRD. IQR, interquartile range; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; CRP, C-reactive protein.
FIGURE 1
The titer distribution of HHV8 among the ESRD and comparison groups
FIGURE 2
The titer distribution of hemoglobin across groups. Participants were grouped according to their HHV8 serostatus into HHV8-seronegative and HHV8-seropositive subjects. Individual hemoglobin levels are plotted
| DISCUSSION
Previous reports have shown that the incidence of KS increases substantially in patients after organ transplantation. While, KS risk increases only in patients infected with HHV8 prior to transplantation, which suggests that KS was associated with a reactivation of HHV8 infection due to immunosuppression. 25 To be able to understand HHV8 epidemiology among ESRD patients, which are candidates for kidney transplantation, is of paramount importance for KS prevention during posttransplantation. In contrast to the relatively abundant information regarding HHV8 epidemiology in ESRD patients worldwide, there is a particularly significant unmet need to understand HHV8 prevalence among patients with ESRD in China. To our knowledge, this is the first epidemiological study to examine HHV8 infection among ESRD patients in mainland China.
In the present study, we found a relatively high prevalence of HHV8 (15.3%) among ESRD patients from eastern China and the prevalence was significantly lower in the comparison group (8.9%). The result is consistent with the previous reports that patients with uremia or hemodialysis had a high prevalence of HHV8 compared to healthy controls. 11, 12, 26 The underlying causes of ESRD, the presence of the uremic status, as well as the application of dialysis, which may undermine the immune system of individual, were the potential risk factors for HHV8 infection in ESRD patients. 27 Furthermore, patients undergoing long-term ESRD are candidates for renal transplantation, a relatively high prevalence of HHV8 in ESRD patients with or without hemodialysis implies a high KS risk after transplantation. A myriad of studies have corroborated that HHV8 is relatively ubiquitous among transplant recipients. [28] [29] [30] However, the moderate seroconversion rate of HHV8 detected in these patients may indicate an early infection of HHV8, 31, 32 which was considered to be a risk factor for posttransplantation KS.
Results from the present study further demonstrated a significant difference in the GMT of the HHV8 antibodies between the ESRD and comparison groups (617.1 vs 291.7; P = 0.042 In addition, there was also a lower hemoglobin concentration in those who were Epstein-Barr virus (EBV) DNA positive at diagnosis. 36 Moreover, a high HIV viral load was associated with a lower concentration of hemoglobin, 37 and blood hemoglobin measurement has been viewed as a predictive indicator for the progression of immunosuppression. 38 Previous data have also shown that low hemoglobin was a risk factor for KS development in kidney transplant recipients. 21 All of these findings indicate a latent relationship between viral infection and plasma hemoglobin level, which could serve as a disease predictor. Our data suggest that HHV8 infection may affect hemoglobin level, and low hemoglobin level and HHV8 infection could interact as a composited risk factor for KS after transplantation. These results suggest that low hemoglobin level in patients with CKD in China needs to be addressed more proactively, HHV8-positive individuals in particular. | 341
A few limitations of the present study should be noted. First, the participants were recruited from a single hospital; the results may not be representative of the overall situation in China or elsewhere in the world. Second, the geographic information for the study subjects were not systematically collected, caution is therefore warranted when interpreting the data. Third, all ESRD patients included in this study were not undergoing hemodialysis, which may lead to an underestimation of HHV8 prevalence in ESRD patients.
In conclusion, the HHV8 prevalence was higher in ESRD patients than people free of renal diseases, so was the GMT of HHV8, an efficient predictor for KS. We also found a negative association between HHV8 and hemoglobin concentration. Given the fact that CKD poses a heavy disease burden on China, [39] [40] [41] there is an important challenge to prevent the development of KS in HHV8+ kidney recipients and to prevent HHV8 reactivation by close monitoring of ESRD patients. 
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